주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
상단영역
UPDATE : 2024-03-28 16:29 (Thurs)
Home
Log in
Join
전체메뉴
기사검색
검색
본문영역
All articles
목록
(
총 :
214 )
기사목록 보기 형태
제목형
요약형
포토형
Whistleblowers, shareholders furious over Medytox’s rebuttal
Jeong Sae-im
2020.04.21 15:04
ImmuneMed confident of drug candidate’s effect on Covid-19
Jeong Sae-im
2020.04.21 13:23
‘Stem cell therapy more effective on Covid-19’
Jeong Sae-im
2020.04.21 10:33
Osang Healthcare wins US nod for Covid-19 test kit
Jeong Sae-im
2020.04.20 11:52
‘Natural Killer cells predict immunotherapy’s efficacy in lung cancer patients’
Jeong Sae-im
2020.04.17 16:06
Medytox CEO charged with making, selling botulinum toxin illegally
Jeong Sae-im
2020.04.17 14:47
Bukwang to test its antiviral drug against Covid-19
Jeong Sae-im
2020.04.16 11:53
What are the odds for successful Invossa trials in US?
Jeong Sae-im
2020.04.14 14:20
FDA OKs resumption of phase-3 Invossa trial in US
Jeong Sae-im
2020.04.13 11:51
Korean diagnostics industry to enjoy unprecedented boom
Jeong Sae-im
2020.04.09 14:30
Executive salaries highest at Samsung Biologics, Celltrion
Jeong Sae-im
2020.04.09 11:10
No Korean firms have entered trials to test COVID-19 drug candidates
Jeong Sae-im
2020.04.08 15:45
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
다음
끝
위로
전체메뉴
All
Hospital
Pharma
Bio
All
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
All
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
ASCO 2020 Highlights
Special Series in Celebration of KBR’s 4th Anniversary
KBR Covering RSNA 2021
Special Series in Celebration of KBR’s 5th Anniversary
Special Report on EULAR 2022
[Top K-Pharma Analysis]
BIO 2023
Opinion
All
Reporter’s Notebook
Journalist’s Column
Congratulatory Remarks
Sponsored
전체메뉴닫기